BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) was the recipient of a large increase in short interest during the month of May. As of May 29th, there was short interest totaling 1,919 shares, an increase of 89.6% from the May 14th total of 1,012 shares. Based on an average daily trading volume, of 9,933 shares, the short-interest ratio is currently 0.2 days.
BioSyent Price Performance
Shares of OTCMKTS:BIOYF opened at $10.00 on Monday. The stock’s 50-day moving average price is $10.46 and its two-hundred day moving average price is $10.10. BioSyent has a 12-month low of $7.63 and a 12-month high of $12.00.
About BioSyent
BioSyent Inc is a specialty biopharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products and medical devices. The company leverages expertise in regulatory affairs, clinical development and manufacturing to deliver a range of branded and generic therapies across multiple therapeutic areas, with particular emphasis on endocrine disorders, supportive care oncology and dermatology.
BioSyent operates a manufacturing facility in Canada that supports both its proprietary portfolio and contract development and manufacturing services (CDMO) for small-molecule products.
Featured Stories
- Five stocks we like better than BioSyent
- 3 ETFs Giving Ready-Made Access to the Discounted International Small-Cap Space
- What to Expect From Q2 Earnings as Tech Strength Broadens
- Viasat’s Orbiting Profits: Space Force Jackpot?
- Robinhood Wants a Bigger Role in IPOs—Here’s Why It Matters
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
